Home > National Drug Code (NDC) > LISINOPRIL AND HYDROCHLOROTHIAZIDE

LISINOPRIL AND HYDROCHLOROTHIAZIDE - 52125-499-20 - (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Alphabetical Index


Drug Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product NDC: 52125-499
Proprietary Name: LISINOPRIL AND HYDROCHLOROTHIAZIDE
Non Proprietary Name: LISINOPRIL AND HYDROCHLOROTHIAZIDE
Active Ingredient(s): 12.5; 10    mg/1; mg/1 & nbsp;   LISINOPRIL AND HYDROCHLOROTHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product NDC: 52125-499
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077912
Marketing Category: ANDA
Start Marketing Date: 20130705

Package Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Package NDC: 52125-499-20
Package Description: 100 TABLET in 1 VIAL (52125-499-20)

NDC Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

NDC Code 52125-499-20
Proprietary Name LISINOPRIL AND HYDROCHLOROTHIAZIDE
Package Description 100 TABLET in 1 VIAL (52125-499-20)
Product NDC 52125-499
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name LISINOPRIL AND HYDROCHLOROTHIAZIDE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130705
Marketing Category Name ANDA
Labeler Name REMEDYREPACK INC.
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 12.5; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]

Complete Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE


General Information